Insulet Corporation (PODD) Stock Analysis: Exploring a 21.77% Potential Upside in the Healthcare Sector
Insulet Corporation (PODD) is a U.S.-based medical device company specializing in innovative insulin delivery systems, holding a market capitalization of $9.79 billion. Analysts project a potential upside of 21.77% for its stock, with an average target price of $171.91, despite recent volatility. The company …